|
|
|
The 14th International Pharma & Med Device Ethics & Compliance Congress, April 20 - 22, 2020, Munich, Germany Features Ethical Interactions with Stakeholders
|
- Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
- Media Partners: Policy & Medicine Compliance Update and Rx Data News
- April 20 - 22, 2020
- Onsite at the Sheraton Munich Arabellapark Hotel
- Munich, Germany
- www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com |
|
SPEAKER PRESENTATION PROPOSALS
|
Speaker/Presentation Proposals for the International Pharma Congress may be submitted through our online form.
- Click Here -
|
|
|
FEATURING ETHICAL INTERACTIONS BETWEEN THE HEALTH CARE SECTOR & OTHER STAKEHOLDERS BY
|
Sadek Beloucif, MD
University Professor, Hospital Practitioner, and Head of Anesthesia-Resuscitation, University of Paris and University Hospital, Bobigny, Chair, National Union of Physicians, Surgeons, Specialists, and Biologists of Public Hospitals, Paris, France |
Christoph Thalheim
Vice CEO and Director External Affairs, European Multiple Sclerosis Platform (EMSP), Brussels, Belgium
|
|
|
MUNICH, GERMANY -- PHARMA UPDATE NEWS SERVICE™ -- DECEMBER 23, 2019: The Fourteenth International Pharmaceutical and Medical Device Ethics and Compliance Congress, www.InternationalPharmaCongress.com, will be held April 20 - 22, 2020 at the Sheraton Munich Arabellapark Hotel in Munich, Germany.
|
|
KEYNOTE SPEAKERS
|
Julie Bonhomme
EFPIA Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium |
Susanne Friedrich, MA
Director, Group Governance, Human, Rights Division Global Policy, Governance, Alliance for Integrity (AfIn), Bonn, Germany |
Aline Lautenberg
General Counsel and Director, Legal & Compliance, MedTech Europe, Brussels, Belgium
|
Sofie Melis
Head of Ethics and Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland |
Christoph Thalheim
Vice CEO and Director External Affairs, European Multiple Sclerosis Platform (EMSP), Brussels, Belgium
|
|
|
|
FEATURED FACULTY
|
Pablo Rojas Abad, LLM
Manager, Legal and Compliance, MedTech Europe, Brussels, Belgium |
Michael Bartke, PhD
Member, Strategic Committee, ETHICS, Former Director Ethics & Compliance, Alexion, Former Director Compliance Management, Daiichi Sankyo Europe, Munich, Germany |
Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Former Co-chair, International Pharmaceutical and Medical Device Compliance Congress, Paris, France
|
Enno Behrendt
Associate Director, Guidepost, Former Head of Compliance for Diagnostic Imaging, Siemens Healthcare GmbH, Berlin, Germany |
Sadek Beloucif, MD
University Professor, Hospital Practitioner and Head of Anesthesia-Resuscitation, University of Paris and University Hospital, Bobigny, Chair, National Union of Physicians, Surgeons, Specialists, and Biologists of Public Hospitals, Paris, France |
Keith Burn
Global Investigations Director, Ipsen, Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS, Former Detective Constable, London Metropolitan Police, Amersham, Slough, UK
|
Thomas Costa, JD
Member, US Board of Directors, Sanofi, Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC |
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK |
Karen Eryou
Head, Ethics & Compliance Programs, Global, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
|
J. Mark Farrar, MSJ, CPA, CFE, CFF
Managing Director, Life Sciences, Navigant, A Guidehouse Company, Atlanta, GA |
George Fife
Partner, Forensic & Integrity Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
|
Betania Glorio, LLM
Global Compliance Officer, Healthcare, Merck KGaA, Former Senior Director, Legal and Compliance EMEA, Horizon Pharma plc and Raptor Pharmaceuticals, Darmstadt, Germany |
Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, GA, USA |
Joseph W. Henein, PharmD
President and Chief Executive Officer, NewBridge Pharmaceuticals, Dubai, UAE
|
Franziska Janorschke
Global Head, Business Practices Office, Novartis International AG, Basel, Switzerland |
Anita Kyung-Hee Kim-Reinartz
Partner, Forensic & Integrity Services, EY, Düsseldorf, Germany |
Adem Koyuncu, MD, PhD (Law)
Partner and Chair, Food, Drug & Device Practice Group, Covington, Brussels, Belgium
|
Tomasz Kruk, LLM, MBA
Head of Compliance, Vifor Pharma, Former Director International Compliance, Mallinckrodt, Former Director Global Ethics & Compliance, Actavis, Zürich, Switzerland |
Lei Li, LLM
Managing Partner, Beijing and Shanghai Offices, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China, Beijing, China |
Rosa Magistri, Esq., CIPP/E
Head of Legal and Compliance Europe, SeaGen International GmbH; Former Regional Director Office of Ethics and Compliance, Western Europe & Canada, Region South & Israel, AbbVie; Former Associate Compliance Director, Shire; Zug, Switzerland
|
Paul J. Melling, JD
Founding Partner, Baker & McKenzie -- CIS, Limited, Moscow, Russia |
Hannes Oswald-Brugel, LLM, PhD
Global Head Pharma Healthcare Compliance, Roche, Vice President, Association of Voluntary Self-Regulation, for the Pharmaceutical Industry ("FSA"), Basel, Switzerland |
Piergiorgio Pepe, MA
EU Law, President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo, Former Compliance Director Western Europe & Canada, AbbVie, Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France
|
Pascale Schmidt
Chief Compliance Officer, F. Hoffmann-La Roche Ltd, Basel, Switzerland |
Cláudia Vaz
Global Value Based HealthCare Consultant, Roche, Value-Based Health Care Consultant, International Consortium for Health, Outcomes Measurement (ICHOM), Basel, Switzerland |
Mariusz Witalis
Partner, Forensic & Integrity Services, EY, Warsaw, Poland
|
|
|
|
2020 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
April 20 - 22, 2020
Sheraton Munich Arabellapark Hotel
Munich, Germany
www.International PharmaCongress.com
|
|
TWENTY-FIRST ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
November 4 - 6, 2020
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
|
SPONSORED BY:
|
|
|
CO CHAIRS
|
Anne-Sophie Bricca, MA, DEA International Law, DES European law
Deputy General Counsel & Senior Director Legal Affairs & Compliance, Terumo BCT, Chair, Ethics and Compliance Group and seats at the Code Committee, MedTech Europe, Brussels Area, Belgium
Stephen Nguyen Duc
Vice-President, Global Head of Human Resources and Ethics & Compliance, Medday Pharmaceuticals; Board Member, Strategic Committee International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Roeland Van Aelst
Regional Vice President -- HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Chairman, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
|
|
GRANTORS
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNER:
|
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
INTERNATIONAL PHARMA CONGRESS IS
|
|
|
|
|
|
